.avif)
.avif)
Teva Email Format
Pharmaceutical Manufacturing
・
50,001-100,000 employees
・
Tel Aviv, Israel
Teva Pharmaceuticals is a global biopharmaceutical company that develops and manufactures innovative medicines, generic drugs, and biosimilars for patients worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@tevapharm.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
1901
Headquarters
Tel Aviv, Israel
Revenue
$10B+
FUNDING Stage
Public
Website
Key Executives
Richard Francis (President and Chief Executive Officer, Member of the Board of Directors), Eli Kalif (Executive Vice President, Chief Financial Officer (CFO)), Matthew Shields (Executive Vice President, Teva Global Operations)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Teva?
Teva uses the first.last format on tevapharm.com, so Jane Smith would be jane.smith@tevapharm.com.
What are Teva's key branded medicine products in its neuroscience portfolio?
Teva's neuroscience portfolio is led by three key branded medicines: AUSTEDO for movement disorders such as tardive dyskinesia and Huntington's disease chorea, AJOVY for migraine prevention, and UZEDY for schizophrenia. Together these brands have been the primary growth drivers for Teva in recent years.
How many people work at Teva globally?
Teva employs approximately 30,298 people worldwide. If you need to reach a specific Teva contact, a tool like Clay can help you find and verify the right person's email address using the first.last@tevapharm.com format.
Where is Teva headquartered and what markets does it operate in?
Teva is headquartered in Tel Aviv, Israel, and operates across major global markets including North America, Europe, and International Markets segments, supplying both generic and innovative medicines to patients in more than 60 countries.
Who leads Teva as its chief executive and what strategy is the company pursuing?
Richard Francis serves as Teva's President and Chief Executive Officer. He is driving the company's Pivot to Growth strategy, which focuses on expanding the innovative pipeline in therapeutic areas including neuroscience, immunology, and immuno-oncology while continuing to grow Teva's world-class generics business.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating